BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23967110)

  • 1. The prognostic significance of IRF8 transcripts in adult patients with acute myeloid leukemia.
    Pogosova-Agadjanyan EL; Kopecky KJ; Ostronoff F; Appelbaum FR; Godwin J; Lee H; List AF; May JJ; Oehler VG; Petersdorf S; Pogosov GL; Radich JP; Willman CL; Meshinchi S; Stirewalt DL
    PLoS One; 2013; 8(8):e70812. PubMed ID: 23967110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of VEGF isoforms and VEGFR transcripts by qRT-PCR and their significance in acute myeloid leukemia.
    Mourah S; Porcher R; Lescaille G; Rousselot P; Podgorniak MP; Labarchède G; Naimi B; Medioni J; Dombret H; Calvo F
    Int J Biol Markers; 2009; 24(1):22-31. PubMed ID: 19404919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
    Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
    J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of IRF8 inhibits the growth of acute myeloid leukemia cells.
    Zhuang H; Li F; Xu Y; Pei R; Chen D; Liu X; Li S; Ye P; Yuan J; Lian J; Lu Y
    Ann Hematol; 2023 May; 102(5):1063-1072. PubMed ID: 36959484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nore1 inhibits age-associated myeloid lineage skewing and clonal hematopoiesis but facilitates termination of emergency (stress) granulopoiesis.
    Williams O; Hu L; Huang W; Patel P; Bartom ET; Bei L; Hjort E; Hijiya C; Eklund EA
    J Biol Chem; 2023 Jul; 299(7):104867. PubMed ID: 37247756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH
    BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
    Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U
    Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ID1 expression associates with other molecular markers and is not an independent prognostic factor in cytogenetically normal acute myeloid leukaemia.
    Damm F; Wagner K; Görlich K; Morgan M; Thol F; Yun H; Delwel R; Valk PJM; Löwenberg B; Heuser M; Ganser A; Krauter J
    Br J Haematol; 2012 Jul; 158(2):208-215. PubMed ID: 22568493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of WT1 and its target gene IRF8 expression in acute myeloid leukemia and their significance.
    Zhang Q; Zhang Q; Li Q; Liu B; Wang Y; Lin D; Zhou C; Li W; Tang K; Tian Z; Wang M; Wang J; Mi Y
    Int J Lab Hematol; 2015 Aug; 37(4):e67-71. PubMed ID: 25387409
    [No Abstract]   [Full Text] [Related]  

  • 10. NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome.
    Handschuh L; Wojciechowski P; Kazmierczak M; Marcinkowska-Swojak M; Luczak M; Lewandowski K; Komarnicki M; Blazewicz J; Figlerowicz M; Kozlowski P
    J Transl Med; 2018 Aug; 16(1):232. PubMed ID: 30126426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
    Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARP-1 Overexpression as an Independent Prognostic Factor in Adult Non-M3 Acute Myeloid Leukemia.
    Pashaiefar H; Yaghmaie M; Tavakkoly-Bazzaz J; Ghaffari SH; Alimoghaddam K; Momeny M; Izadi P; Izadifard M; Kasaeian A; Ghavamzadeh A
    Genet Test Mol Biomarkers; 2018 Jun; 22(6):343-349. PubMed ID: 29812960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency.
    Cao Z; Budinich KA; Huang H; Ren D; Lu B; Zhang Z; Chen Q; Zhou Y; Huang YH; Alikarami F; Kingsley MC; Lenard AK; Wakabayashi A; Khandros E; Bailis W; Qi J; Carroll MP; Blobel GA; Faryabi RB; Bernt KM; Berger SL; Shi J
    Mol Cell; 2021 Sep; 81(17):3604-3622.e10. PubMed ID: 34358447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia.
    Damm F; Oberacker T; Thol F; Surdziel E; Wagner K; Chaturvedi A; Morgan M; Bomm K; Göhring G; Lübbert M; Kanz L; Fiedler W; Schlegelberger B; Heil G; Schlenk RF; Döhner K; Döhner H; Krauter J; Ganser A; Heuser M
    J Clin Oncol; 2011 Feb; 29(6):682-9. PubMed ID: 21205756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
    Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
    Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia.
    Zhang TJ; Zhou JD; Yang DQ; Wang YX; Wen XM; Guo H; Yang L; Lian XY; Lin J; Qian J
    J Cell Physiol; 2018 Aug; 233(8):5838-5846. PubMed ID: 29219176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.
    Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G
    Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognosis analysis of
    Zhang T; Zhao Y; Zhao Y; Zhou J
    Aging (Albany NY); 2020 Mar; 12(6):5031-5047. PubMed ID: 32209730
    [No Abstract]   [Full Text] [Related]  

  • 19. Genome-wide identification of FHL1 as a powerful prognostic candidate and potential therapeutic target in acute myeloid leukaemia.
    Fu Y; Xu M; Cui Z; Yang Z; Zhang Z; Yin X; Huang X; Zhou M; Wang X; Chen C
    EBioMedicine; 2020 Feb; 52():102664. PubMed ID: 32062360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients.
    Wang F; Tian X; Zhou J; Wang G; Yu W; Li Z; Fan Z; Zhang W; Liang A
    Mol Med Rep; 2018 Aug; 18(2):1473-1484. PubMed ID: 29901168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.